RASCHI, ELENA
RASCHI, ELENA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies
2024 C. Bodio, A. Milesi, P.A. Lonati, C.B. Chighizola, A. Mauro, L.G. Pradotto, P.L. Meroni, M.O. Borghi, E. Raschi
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
2020 A. Bortoluzzi, C.B. Chighizola, M. Fredi, E. Raschi, C. Bodio, D. Privitera, A. Gonelli, E. Silvagni, M. Govoni, I. Cavazzana, P. Airo, P.L. Meroni, A. Tincani, F. Franceschini, S. Piantoni, F. Casciano
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
2020 E. Raschi, D. Privitera, C. Bodio, P.A. Lonati, M.O. Borghi, F. Ingegnoli, P.L. Meroni, C.B. Chighizola
Vitamin D and anti-phospholipid antibody syndrome : A comprehensive review
2018 R. Gualtierotti, A. Di Giacomo, E. Raschi, M.O. Borghi, P.L. Meroni
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
2018 E. Raschi, C.B. Chighizola, L. Cesana, D. Privitera, F. Ingegnoli, C. Mastaglio, P.L. Meroni, M.O. Borghi
Serum chemerin in systemic sclerosis : a novel marker of early diffuse disease?
2017 C.B. Chighizola, E. Raschi, D. Privitera, A.F. Luppino, C. Artusi, T. Schioppo, C. Mastaglio, F.A. Ingegnoli, M.O. Borghi, P. Meroni
The challenges of lupus anticoagulants
2016 C.B. Chighizola, E. Raschi, A. Banzato, M.O. Borghi, V. Pengo, P.L. Meroni
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells
2016 C.B. Chighizola, F. Pregnolato, E. Raschi, C. Grossi, D. Gentilini, M.O. Borghi, P. Chen, P.L. Meroni
Mechanisms of Action of the Antiphospholipid Antibodies
2016 C.B. Chighizola, E. Raschi, M.O. Borghi, P. Meroni
Update on the pathogenesis and treatment of the antiphospholipid syndrome
2015 C.B. Chighizola, E. Raschi, M.O. Borghi, P.L. Meroni
Chemerin serum levels in systemic sclerosis: a novel marker of early and active disease?
2015 C. Chighizola, E. Raschi, T. Schioppo, C. Artusi, F. Ingegnoli, M.O. Borghi, P.L. Meroni
Toll like receptors : a crossroad in scleroderma etiopathogenesis
2014 C. Chighizola, E. Raschi, L. Cesana, S. Uceda, M. Borghi, P. Meroni
The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease
2014 C.B. Chighizola, E. Raschi, L. Cesana, S. Zeni, M.O. Borghi, P.L. Meroni
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement
2013 M. Truchetet, N. Brembilla, E. Montanari, P. Lonati, E. Raschi, S. Zeni, L. Fontao, P. Meroni, C. Chizzolini
Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts : differential effects in healthy and systemic sclerosis fibroblasts
2013 N.C. Brembilla, E. Montanari, M. Truchetet, E. Raschi, P. Meroni, C. Chizzolini
Obstetric and vascular APS : same autoantibodies but different diseases?
2012 P.L. Meroni, E. Raschi, C. Grossi, F. Pregnolato, L. Trespidi, B. Acaia, M.O. Borghi
Antiphospholipid syndrome: not only an antibody-mediated disease
2011 R. Gualtierotti, M.O. Borghi, E. Raschi, F. Tedesco, P.L. Meroni
Pathogenesis of antiphospholipid syndrome : understanding the antibodies
2011 P. Meroni, M.O. Borghi, E. Raschi, F. Tedesco
TLR-4 and Annexin A2 Involvement in endothelial cell activation by anti-phospholipid antibodies : specific silencing by small interfering RNAs
2010 E. Raschi, V. Broggini, M.O. Borghi, C. Grossi, P. Meroni
Effect of TNFalpha blocking agents on mRNA and miRNA profile in RA patients
2010 P. Meroni, F. D'Amelio, V. Broggini, E. Raschi, P.C. Sarzi Puttini, M.O. Borghi, M. Locati